awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q55022663-5E53E4AB-765C-4D91-B560-5A7647970653
Q55022663-5E53E4AB-765C-4D91-B560-5A7647970653
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55022663-5E53E4AB-765C-4D91-B560-5A7647970653
Absorption, distribution, metabolism and excretion (ADME) of the ALK inhibitor alectinib: results from an absolute bioavailability and mass balance study in healthy subjects.
P2860
Q55022663-5E53E4AB-765C-4D91-B560-5A7647970653
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55022663-5E53E4AB-765C-4D91-B560-5A7647970653
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0677663a554e3d7267e9ccaf1166d1faf7a7bff1
P2860
Alectinib in Crizotinib-Refractory ALK-Rearranged Non-Small-Cell Lung Cancer: A Phase II Global Study.